#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Guidance for Developers of Health Research Reporting Guidelines


article has not abstract


Vyšlo v časopise: Guidance for Developers of Health Research Reporting Guidelines. PLoS Med 7(2): e32767. doi:10.1371/journal.pmed.1000217
Kategorie: Guidelines and Guidance
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000217

Souhrn

article has not abstract


Zdroje

1. GlasziouP

MeatsE

HeneghanC

ShepperdS

2008 What is missing from descriptions of treatment in trials and reviews? BMJ 336 (7659) 1472 4

2. ZhangD

YinP

FreemantleN

JordanR

ZhongN

2008 An assessment of the quality of randomised controlled trials conducted in China. Trials 9 22

3. ScalesCD

NorrisRD

PremingerGM

ViewegJ

PetersonBL

2008 Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature. J Urol 180 1463 1467

4. LaiTYY

WongVWY

LamRF

ChengACO

LamDSC

2008 Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals. Ophthalmic Epidemiol 14 390 398

5. ChanAW

AltmanDG

2005 Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 365 (9465) 1159 62

6. MoherD

TetzlaffJ

TriccoA

SampsonM

AltmanDG

2007 Epidemiology and reporting characteristics of systematic reviews. PLoS Med 4 e78 doi:10.1371/journal.pmed.0040078

7. MoherD

2007 Reporting research results: a moral obligation for all researchers. Can J Anaesth 54 331 335

8. AltmanDG

SimeraI

HoeyJ

MoherD

SchulzK

2008 EQUATOR: reporting guidelines for health research. Lancet 31 1149 1150

9. MoherD

SimeraI

SchulzK

MillerD

GrimshawJ

Reporting Guidelines for Clinical Research: A Systematic Review. 6th International Congress on Peer Review and Biomedical Publication, Vancouver. Available: http://www.ama-assn.org/public/peer/abstracts-0912.pdf. Accessed 31 October 2009

10. MurphyMK

BlackNA

LampingDL

McKeeCM

SandersonCFB

1998 Consensus development methods, and their use in clinical guideline development. Health Technol Assess 2 1 88

11. O'TooleLB

1997 MRC uses checklist similar to CONSORTs. BMJ 314 1127

12. DavidoffF

BataldenP

StevensD

OgrincG

MooneyS

2008 Publication guidelines for improvement studies in health care: evolution of the SQUIRE Project. Ann Intern Med 149 670 6

13. BoutronI

MoherD

TugwellP

GiraudeauB

PoiraudeauS

2005 Assessing the quality of randomized controlled trials: a checklist to evaluate a report of a nonpharmacological trial: (CLEAN NPT). J Clin Epidemiol 58 123 1240

14. AltmanDG

MoherD

2005 Developing guidelines for reporting healthcare research: scientific rationale and procedures. (In Spanish) Med Clin (Barc) 125 Suppl 1 8 13

15. von ElmE

AltmanDG

EggerM

PocockSJ

GotzschePC

2007 The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147 573 7

16. LittleJ

HigginsJ

IoannidisJPA

MoherD

GagnonF

2009 STROBE Extension to Genetic Association studies: STREGA (STrengthening the REporting of Genetic Association studies. PLoS Med 6 e22 doi:10.1371/journal.pmed.1000022

17. BossuytPM

ReitsmaJB

BrunsDE

GatsonisCA

GlasziouPP

2003 for the STARD group. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Ann Intern Med 138 40 44

18. BoutronI

MoherD

AltmanDG

SchulzKF

RavaudP

the CONSORT Group 2005 Reporting of nonpharmacologic treatment interventions: an extension of the CONSORT Statement. Ann Intern Med 148 W-60 W-66

19. DavidsonKW

GoldsteinM

KaplanRM

KaufmannPG

KnatterudGL

2003 Evidence-based behavioral medicine: what is it and how do we achieve it? Ann Behav Med 26 161 71

20. SchulzKF

ChalmersI

HayesRJ

AltmanDG

1995 Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 408 412

21. DwanK

AltmanDG

ArnaizJA

BloomJ

ChanAW

2008 Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 3 e3081 doi:10.1371/journal.pone.0003081

22. De AngelisC

DrazenJM

FrizelleFA

HaugC

HoeyJ

2004 Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 364 911 912

23. WhittingtonCJ

KendallT

FonagyP

CottrellD

CotgroveA

2004 Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363 1341 1345

24. SimeraI

AltmanDG

MoherD

SchulzKF

HoeyJ

2008 Guidelines for reporting health research: the EQUATOR Network's survey of guideline authors. PLoS Med 5 e139 doi:10.1371/journal.pmed.0050139

25. HopewellS

ClarkeM

MoherD

WagerE

MiddletonP

2008 CONSORT for reporting randomized controlled trials in journal and conference abstracts. Lancet 371 281 283

26. TriccoAC

PhamB

BrehautJ

TetroeJ

CappelliM

2009 An international survey suggested that unpublished systematic review exist. J Clin Epidemiol 62 617 623

27. GagnierJJ

BoonH

RochonP

MoherD

BarnesJ

2006 Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement. Ann Intern Med 144 364 367

28. BossuytPM

ReitsmaJB

BrunsDE

GatsonisCA

GlasziouPP

2003 Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Radiology 226 24 28

29. BossuytPM

ReitsmaJB

BrunsDE

GatsonisCA

GlasziouPP

2003 Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Clin Chem 49 1 6

30. MoherD

LiberatiA

TetzlaffJ

AltmanDG

the PRISMA Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 6 e1000097 doi:10.1371/journal.pmed.1000097

31. MoherD

LiberatiA

TetzlaffJ

AltmanDG

the PRISMA Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Ann Intern Med 151 264 269

32. MoherD

LiberatiA

TetzlaffJ

AltmanDG

the PRISMA Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3 123 130

33. MoherD

LiberatiA

TetzlaffJ

AltmanDG

the PRISMA Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. BMJ 339 332 336

34. MoherD

LiberatiA

TetzlaffJ

AltmanDG

the PRISMA Group 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. J Clin Epidemiol 62 1006 12

35. MeinertCL

1998 Beyond CONSORT: need for improved reporting standards for clinical trials. JAMA 279 1487 1489

36. AltmanDG

2005 Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ 330 1056 1057

37. SmidtN

RutjesAW

van der WindtDA

OsteloRW

BossuytPM

2006 The quality of diagnostic accuracy studies since the STARD statement: has it improved? Neurology 67 792 797

38. HopewellS

AltmanDG

MoherD

SchulzKF

2008 Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal ‘Instructions to Authors’. Trials 9 20

39. PlintAC

MoherD

MorrisonA

SchulzKF

AltmanDG

2006 Does the CONSORT checklist improve the quality of reports of randomized controlled trials: a systematic review. Med J Aust 185 263 267

40. ShojaniaK

SampsonM

JiJ

AnsariMT

DoucetteS

2007 How quickly do systematic reviews go out of date: A survival analysis. Ann Intern Med 147 224 233

41. SmithBA

LeeHJ

LeeJH

ChoiM

JonesDE

2008 Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the Consolidated Standards of Reporting Trials (CONSORT). Nurs Outlook 56 31 37

42. PradySL

RichmondSJ

MortonVM

MacPhersonH

2008 A Systematic Evaluation of the Impact of STRICTA and CONSORT Recommendations on Quality of Reporting for Acupuncture Trials. PLoS ONE 3 e1577 doi:10.1371/journal.pone.0001577

43. NarahariSR

RyanTJ

AggithayaMG

BoseKS

PrasannaKS

2008 Evidence-based approaches for the ayurvedic traditional herbal formulations: towards an ayurvedic CONSORT model. J Altern Complement Med 14 769 776

44. MoherD

SchulzKF

AltmanDG

for the CONSORT group 2001 The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. Lancet 357 1191 1194

45. AltmanDG

SchulzKF

MoherD

EggerM

DavidoffF

2001 The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134 663 694

46. BossuytPM

ReitsmaJB

BrunsDE

GatsonisCA

GlasziouPP

2003 Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Explanation and Elaboration. Ann Intern Med 138 W1 W12

47. VandenbrouckeJP

von ElmE

AltmanDG

GøtzschePC

MulrowC

2007 The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18 805 835

48. LiberatiA

AltmanDG

TetzlaffJ

MulrowC

GøtzscheP

2009 The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6 e1000100 doi:10.1371/journal.pmed.1000100

49. CampbellMK

ElbourneDR

AltmanDG

for the CONSORT group 2004 CONSORT statement: extension to cluster randomised trials. BMJ 328 702 708

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2010 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#